Could a common painkiller reduce breast cancer risk?
Prevention
Completed
This trial investigates whether sulindac, an NSAID, can reduce breast density in postmenopausal women at elevated risk for breast cancer. High breast density is a known risk factor for the disease. Participants take sulindac or a placebo daily for 12 months, and changes in breast…
Phase: PHASE2 • Sponsor: Alison Stopeck • Aim: Prevention
Last updated Jul 19, 2026 00:00 UTC